Ureaplasma Infection Treatment Guidelines
First-Line Treatment
- The Centers for Disease Control and Prevention recommends doxycycline 100 mg orally twice daily for 7 days as the first-line treatment for Ureaplasma urethritis, achieving 91% susceptibility rates 1, 2, 3
Alternative Regimens
- Azithromycin 1 g orally as a single dose is preferred when compliance with 7-day therapy is questionable, with a susceptibility rate of 71% 2, 3
- Erythromycin base 500 mg orally four times daily for 7 days or erythromycin ethylsuccinate 800 mg orally four times daily for 7 days can be used as alternative regimens 1, 2, 3
Management of Treatment Failure
- For persistent symptoms after doxycycline, re-treat with the initial regimen if non-compliance or partner re-exposure occurred 1, 2, 3
- After documented doxycycline failure, azithromycin 500 mg on day 1, then 250 mg daily for 4 days can be used 3, 4
Partner Management
- All sexual partners with contact within 60 days of diagnosis must be evaluated and treated 2, 3, 4
- Both patient and partners must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 2, 3, 4
Follow-Up Strategy
- Test-of-cure is NOT routinely recommended after doxycycline or azithromycin unless symptoms persist or reinfection is suspected 3
- If performed, test no earlier than 3 weeks after treatment completion 3
Critical Clinical Considerations
- Ureaplasma parvum should generally NOT be treated, as its pathogenic role is questionable 5
- Only U. urealyticum (not U. parvum) is considered a true urethritis pathogen 5
- Always exclude Chlamydia trachomatis, Neisseria gonorrhoeae, and M. genitalium before attributing urethritis to Ureaplasma 6
Treatment for Ureaplasma Infection
Critical Diagnostic Distinction Before Treatment
- Only Ureaplasma urealyticum (not U. parvum) warrants treatment, as recent data confirm U. ureaplasum as a true urethritis pathogen while U. parvum's pathogenic role remains questionable 7
- Do not use fluoroquinolones empirically if the patient has used them in the last 6 months or comes from a urology department where resistance rates are higher 7